Microbial regulation of intestinal tuft cell homeostasis
肠道簇细胞稳态的微生物调节
基本信息
- 批准号:10638381
- 负责人:
- 金额:$ 14.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AllergicAllergic DiseaseAllergic inflammationAreaButyratesCalibrationCell CountCell Differentiation processCell LineageCellsChromatinChronicCollaborationsDataDevelopmentDevelopment PlansDiseaseDisease modelEnvironmentEpigenetic ProcessEpithelial CellsEpitheliumFibrosisFood HypersensitivityGastrointestinal tract structureGnotobioticGoalsHDAC3 geneHealthHelminthsHistone Deacetylase InhibitorHomeostasisHumanHypersensitivityImmune System DiseasesImmune responseImmunityIndividualInfectionInflammatoryInflammatory Bowel DiseasesInterventionIntestinal DiseasesIntestinesLinkMediatingMentorsMentorshipMetagenomicsMicrobeModelingModernizationMolecularMucosal Immune ResponsesMusOrganoidsOutcome StudyParasitic infectionPathogenesisPathway interactionsPediatric HospitalsProductionRegulationResearchResearch PersonnelRoleSignal TransductionSpecialized Epithelial CellStimulusTestingTrainingTransgenic MiceTransgenic OrganismsTranslatingWorkcareercareer developmentcommensal bacteriacytokinedesignfightinggut inflammationgut microbiotahelminth infectionhost microbiotaimmunoregulationimprovedinhibitorinnovationinsightintestinal epitheliummicrobialmicrobiotamouse modelnovelnovel strategiesnovel therapeutic interventionpathogenpreventresponsesingle cell analysissingle-cell RNA sequencingstem cellstissue repairtool
项目摘要
Helminth infections and allergic diseases impact billions of individuals worldwide. While induction of type 2
immune responses are necessary for combatting helminth pathogens, inappropriate type 2 immunity triggers
inflammatory and allergic conditions. Therefore, improved understanding of mechanisms that control type 2
immune responses are needed. The intestinal microbiota continually influence immune responses, and several
studies have demonstrated that microbiota-derived factors dampen type 2 immunity. Intestinal tuft cells are
specialized epithelial cells that are essential for sensing luminal signals and initiating downstream type 2 immune
responses. My preliminary data indicate that the microbiota regulate tuft cell homeostasis and tuft cell-dependent
type 2 immune responses in the intestine. Studies outlined in this proposal will directly test (i) how intestinal stem
cells instruct tuft cell differentiation, and (ii) how commensal bacteria impact tuft cell-dependent type 2 immunity.
Collectively, these studies will provide new insights into how the microbiota direct intestinal epithelial
differentiation to instruct intestinal immune responses, and will guide novel microbiota-based approaches for
investigating and treating type 2-driven intestinal diseases.
My career goal is to establish myself as a successful investigator studying microbiota-regulated intestinal
diseases. To progress towards this goal, I propose in this application to dissect interactions between the
microbiota, epithelial cell differentiation, and mucosal immune responses. I will specifically concentrate on
developing expertise in four new areas that will facilitate my transition to independence: 1) gnotobiotics and
metagenomics, 2) type 2-driven murine disease models, 3) epithelial development and human intestinal
organoids, and 4) chromatin and single cell analyses. My mentors, Dr. Alenghat and Dr. Wells, along with the
exceptional scientific and intellectual environment at Cincinnati Children’s Hospital will enable me to utilize
modern, innovative approaches in my research and collaborate with top investigators. Over the next five years,
I fully anticipate that my background, in conjunction with the career development plan outlined in my application,
will allow me to successfully carry out the proposed project. The mentoring and training I will receive will enable
me to successfully transition to an independent research career directed towards fundamental advances in
intestinal immunity, as well as innovative and targeted strategies for investigating microbiota-sensitive diseases.
蠕虫感染和过敏性疾病会影响全球数十亿个人。而诱导2型
免疫反应对于打击蠕虫病原体是必需的,不适当
炎症和过敏性条件。因此,改善了控制2型机制的理解
需要免疫反应。肠道菌群不断影响免疫反应,有几个
研究表明,微生物群衍生的因子该死的2型免疫培养基。肠簇细胞是
专门的上皮细胞,对于传感腔信号和下游2型免疫启动至关重要
回答。我的初步数据表明,微生物群调节簇细胞稳态和簇细胞依赖性
肠道中的2型免疫回报。该提案中概述的研究将直接检验(i)肠干
细胞指导簇簇细胞分化,以及(ii)共生细菌如何影响簇状细胞依赖性2型免疫培养。
总的来说,这些研究将为微生物群如何直接肠上皮提供新的见解
分化以指导肠道免疫调查,并将指导基于微生物群的新方法
研究和治疗2型肠道疾病。
我的职业目标是将自己确立为研究微生物群调节的肠道的成功研究者
疾病。为了朝着这个目标迈进,我建议在此应用中剖析
微生物群,上皮细胞分化和粘膜免疫反应。我将专门专注于
在四个新领域发展专业知识,这将有助于我向独立过渡:1)Gnotobiotics和
宏基因组学,2)2型2驱动的鼠类疾病模型,3)上皮发育和人类肠道
器官,4)染色质和单细胞分析。我的导师Alenghat博士和Wells博士以及
辛辛那提儿童医院的卓越科学和智力环境将使我能够利用
在我的研究中,现代,创新的方法与顶级研究人员合作。在接下来的五年中,
我完全期望我的背景与我的申请中概述的职业发展计划一起
将允许我成功执行拟议的项目。我将获得的心理和培训将启用
我成功地过渡到针对基本进步的独立研究职业
肠道免疫,以及研究微生物群敏感性疾病的创新和有针对性的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emily M. Eshleman其他文献
<strong>142</strong>: A mechanism for the anti-inflammatory effects of type I IFNs in myeloid cells
- DOI:
10.1016/j.cyto.2013.06.145 - 发表时间:
2013-09-01 - 期刊:
- 影响因子:
- 作者:
Staci J. Kearney;Christine Delgado;Emily M. Eshleman;Krista K. Hill;Brian P. O’Connor;Laurel L. Lenz - 通讯作者:
Laurel L. Lenz
Emily M. Eshleman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emily M. Eshleman', 18)}}的其他基金
Epithelial antigen presentation in regulation of the host-microbiota relationship
上皮抗原呈递在调节宿主-微生物群关系中的作用
- 批准号:
10374870 - 财政年份:2020
- 资助金额:
$ 14.18万 - 项目类别:
相似国自然基金
基于社会生态理论的儿童过敏性疾病及其健康影响的多维风险因素识别、动态预警及健康管理策略研究
- 批准号:72374059
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
钙结合蛋白S100A4通过RAGE-PPARg调控肥大细胞代谢及其对过敏性疾病的作用
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
空气污染与食物过敏原早期暴露对儿童第二波过敏性疾病的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
钙结合蛋白S100A4通过RAGE-PPARg调控肥大细胞代谢及其对过敏性疾病的作用
- 批准号:82260324
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
治疗过敏性疾病相关激酶靶点群的确定及先导化合物发现
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Innate immune regulation of lung inflammation through mitochondrial dynamics
通过线粒体动力学调节肺部炎症的先天免疫
- 批准号:
10659953 - 财政年份:2023
- 资助金额:
$ 14.18万 - 项目类别:
NHERF1 regulates MRGPRX2/MrgprB2 responses in mast cells
NHERF1 调节肥大细胞中的 MRGPRX2/MrgprB2 反应
- 批准号:
10711042 - 财政年份:2023
- 资助金额:
$ 14.18万 - 项目类别:
Mechanism of Transcriptional Regulation of Th2 Cell Development
Th2细胞发育的转录调控机制
- 批准号:
10716014 - 财政年份:2023
- 资助金额:
$ 14.18万 - 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
- 批准号:
10586398 - 财政年份:2023
- 资助金额:
$ 14.18万 - 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 14.18万 - 项目类别: